Related Experiment Video
Updated: Dec 26, 2025

07:42
Quantification of the Potential Impact of Glyphosate-Based Products on Microbiomes
Published on: January 10, 2022
4.6K
Accounting for Multiple Comparisons in Statistical Analysis of the Extensive Bioassay Data on Glyphosate
Kenny Crump1, Edmund Crouch2, Daniel Zelterman3
1Ruston, Louisiana 71270.
Summary
Glyphosate is not a strong animal carcinogen, contrary to previous findings. This study used advanced statistical methods to re-analyze glyphosate rodent bioassays, finding no conclusive evidence of cancer risk in animals.
Area of Science:
- Toxicology
- Carcinogenesis
- Environmental Health
Background:
- Glyphosate is a globally prevalent herbicide.
- The International Agency for Research on Cancer (IARC) classified glyphosate as a probable human carcinogen in 2015.
- Concerns exist regarding the potential carcinogenicity of glyphosate in experimental animals.
Purpose of the Study:
- To re-evaluate the carcinogenicity of glyphosate in rodent bioassays.
- To address statistical limitations in previous analyses of glyphosate cancer data.
- To provide a more accurate assessment of glyphosate's animal carcinogenicity.
Main Methods:
- Analysis of 10 glyphosate rodent bioassays using a multiresponse permutation procedure.
- Adjustment for a large number of tumor types to control false-positive probabilities.
- Evaluation of permutation tests based on p-values from dose-response trend tests.
Main Results:
- False-positive probabilities for carcinogenicity were calculated (e.g., .06, .08 for p ≤ .01).
- More evidence for negative dose-response trends was observed than positive trends.
- No strong statistical evidence for glyphosate being an animal carcinogen was found.
Conclusions:
- The discrepancy with IARC findings is attributed to IARC's failure to account for multiple testing.
- This study provides a more robust analysis of glyphosate animal carcinogenicity data.
- Glyphosate does not show strong evidence of being an animal carcinogen based on this re-analysis.
Related Concept Videos
Multiple Comparison Tests
4.3K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
4.3K
Comparing the Survival Analysis of Two or More Groups
494
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
494

